The heptapeptide Selank is one of the newer peptides undergoing extensive research of late. Researchers are trying to understand what the peptide does, how it interacts with different systems within the body of the different test subjects, and what the effects of this peptide are under different experimental circumstances. So far, researchers are learning quite a bit about how this peptide is nearly a synthetic reproduction of tuftsin, which most bodies create naturally within the spleen.
The Origins of Selank
Selank was originally developed out of the Institute of Molecular Genetics, at the Academy of Sciences in Russia. The current peptide sequence has been found to be Thr-Lys-Pro-Arg-Pro-Gly-Pro. This is showing researchers that it can inhibit the enzymes that are involved in the degradation of endogenous peptides as well as enkephalins. That is where the basis of the research began with selank.
The initial results were very promising when researchers began looking at the anxiolytic and nootropic effects of the peptide on the test subjects. This peptide began modulating Interleukin-6 expressions, and the brain-derived neurotropic factors in the test subjects of choice, in this case, rats.
What Researchers Are Discovering About Selank
So far, the most important discovery that researchers have made about selank is that it is showing great promise in reducing anxiety within the test subjects it has been tested on. There are no sedation effects being exhibited by the test subjects, but the anxiety and fear the animals were showing prior to exposure to selank is greatly reduced, or even gone in some cases. To make matters even better, this peptide has not shown any type of withdrawal symptoms after exposure to the peptide has stopped, and there are no signs of addictive tendencies being shown by any of the test subjects after repeated exposure to the peptide.
Another benefit that researchers have found is that the risk toxicity associated with exposure to selank is incredibly low. In fact, in numerous experiments, researchers exposed test subjects to much higher than normal doses, up to 500 times the standard dose, and found no ill effects. This makes the risk of any type of overdose with this peptide nearly negligible, allowing for researchers to be able to continuously perform experiments without having to worry about giving any of the test subjects a dose that is slightly too high, harming the animal.
This is helping researchers understand the importance in the regulation of both enkephalins and the endogenous peptides within the body when it comes to controlling anxiety. The more test subjects are exposed to this peptide, the more researchers are learning about the right levels each body needs to have in order to control anxiety. Through this discovery, researchers have also found that the more each test subject is exposed to selank, the stronger their immune system becomes, and the better their body is able to fight off illnesses.
DISCLAIMER: This peptide was solely created for research and experimental purposes, and should not be used for any purpose outside of experiments and research. Ingestion of selank is dangerous, and should not be attempted under any circumstances. Researchers using this peptide should wear all types of protective gear when using it for experiments, and should incidental contact occur, all attire should be thoroughly cleaned immediately.
Selank has the capability of teaching researchers a lot when it comes to how to boost an immune system and how to avoid anxiety. The more researchers can learn through test subject experimentation with selank, the more they will be able to learn about how the body works, and the better they will be able to set up future experiments to continue learning even more.
